Stephen Appezzato Key Takeaways Federal exclusion of weight-loss drugs forces Medicare GLP-1 utilization into other FDA-approved indications, even as 2024 Part D gross GLP-1 spending reached $27.5 billion across 21.8 million claims
Red flags include no intake form, no mention of a supervising physician, aggressive upselling during the appointment, and providers who cannot explain what form of B12 they are injecting or why
Sermorelin supports natural growth hormone (GH) production and may provide broader metabolic and muscle growth benefits with fewer concerns about dependency
Now, for the first time in a long time, real downward pressure on prices is starting to show up
It can be found in tea and red wine Booster Ingredients N-Acetyl-L-Cysteine, 200mg: -has been shown to augment the Glutathione reserves in the body
Meta-analyses of randomized clinical trials (RCTs) on GLP-1RA type drugs show an overall 37% increased risk of gallbladder or biliary diseases (1,5,6)